myirislogo
14 October, 2019 11:07 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 127.70 5.23
State Bank O 257.00 0.98
Tata Stl 350.60 3.30
Ong Corp 132.40 2.56
Icici Bank 429.30 0.21
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Ipca Laboratories Limited
Ipca Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524494NSE:IPCALABBloomberg:IPCA@INReuters:IPCA.BO
Market Lot: 1Face Value: 2ISIN Demat: INE571A01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
16-JUN-17 Almost all drugs manufactured by Ipca Laboratories at its facilities at Pithampur, Silvassa and Ratlam have been banned from the US market by US Food and Drug Administration (USFDA). 11-AUG-16 Ipca Laboratories announced a sharp rise in standalone net profit for the quarter ended June 2016. During the quarter, the profit of the company rose 2.27 times to Rs 475.70 million from Rs 209.20 million in the same quarter previous year. 08...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Ipca Labs slips after USFDA bans import of drugs from 3 plants  -IRIS 16-Jun-17
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2019(3)31-Mar-2019 (12)31-Mar-2018(12)
Net sales 10110.1036331.5024371.60
Other Income194.30545.90395.40
Total Income10304.4036877.4024767.00
Cost of goods sold-8624.80-31303.5021656.20
OPBDIT18929.2068180.903110.80
PAT1320.504549.102331.10
Gross Block---
Equity capital-0.00252.40
EPS (Rs.)-0.00-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA-
Debt / Equity (x)---
Operating margin (% of OI)183.7184.912.6
Net margin (% of OI)12.812.3 9.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
48, Kandivli Industrial Estate
Kandivli (West)
Mumbai
Maharashtra-400 067
PHONE
(022) 6647 4444
FAX
(022) 2868 6613
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer